Procyon Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Procyon Advisors's AMGN Position: Q2 2026 in Review
Procyon Advisors reduced its Amgen (AMGN) stake by 1.7% in Q2 2026, selling an estimated $40.7K and leaving 6,850 shares worth $2.48M. The position accounts for 0.11% of the portfolio, ranked #166.
Procyon Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.32M in Q1 2025. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Procyon Advisors held 6,850 shares of Amgen worth $2.48M as of Q2 2026.
- Procyon Advisors sold 119 Amgen shares in Q2 2026, an estimated $40.7K.
- Amgen made up 0.11% of Procyon Advisors's portfolio in Q2 2026, its #166 holding.
- Procyon Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Procyon Advisors's Amgen position peaked at $3.32M in Q1 2025.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.